Old Republic International
ORI
$0.00
-0.10%
Old Republic International Corporation is a diversified insurance underwriter operating primarily in two segments: Specialty Insurance and Title Insurance, providing a range of products including commercial auto, workers' compensation, aviation, and extended warranty insurance. The company is a long-established, niche player in the commercial insurance market, known for its underwriting discipline and focus on specific, often less-cyclical, lines of business. The current investor narrative centers on its defensive characteristics and dividend reliability amid a challenging market environment, as evidenced by its significant underperformance relative to the broader market over the past year, which raises questions about its growth prospects and sensitivity to economic cycles.…
ORI
Old Republic International
$0.00
ORI 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Old Republic International's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
1 analysts
Implied Upside
—
vs. current price
Analyst Count
1
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage for ORI is extremely limited, with only one analyst providing estimates, which implies this is a small-to-mid-cap stock with limited institutional research interest, leading to potentially higher volatility and less efficient price discovery. The single analyst projects an EPS range of $3.31 to $3.39, with a consensus of $3.35, and a revenue estimate of approximately $10.59 billion, but no specific price targets or buy/sell/hold ratings are provided in the dataset. The lack of a consensus price target and rating distribution prevents calculation of implied upside/downside, and the narrow EPS estimate range suggests some conviction in near-term earnings, but the overall minimal coverage is a significant data gap for investors.
Bulls vs Bears: ORI Investment Factors
The evidence presents a stark contrast between strong, value-oriented fundamentals and weak, deteriorating market sentiment. The bull case is anchored in ORI's profitability (15.83% ROE), financial strength (D/E of 0.27), and deep value valuation (P/E ~11.9x). The bear case is dominated by its catastrophic relative performance, lack of analyst interest, and broken technical picture. Currently, the bearish market sentiment holds stronger immediate evidence, as the stock's price action reflects a complete dismissal of its solid fundamentals. The single most important tension is whether the market will eventually recognize and reward the company's fundamental value and defensive yield, or if the stock will remain in a value trap due to its lack of growth catalysts and visibility.
Bullish
- Strong Profitability and Capital Efficiency: The company delivers a robust Return on Equity (ROE) of 15.83%, significantly above typical industry benchmarks, indicating highly efficient use of shareholder capital. This is supported by a solid operating margin of 13.02% and a trailing net margin of 10.30%, demonstrating consistent underwriting profitability.
- Conservative Balance Sheet with Ample Liquidity: A low debt-to-equity ratio of 0.27 indicates minimal financial leverage and a strong capacity to weather economic downturns. Furthermore, a current ratio of 3.40 provides exceptional liquidity, far exceeding the typical threshold of 1.0, ensuring the company can comfortably meet its short-term obligations.
- Attractive Valuation Multiples: The stock trades at a trailing P/E of 11.89x and a forward P/E of 11.61x, which is in line with or at a discount to typical diversified insurers. The Price-to-Cash-Flow ratio of 9.56x and Price-to-Sales of 1.22x further suggest the market is not overvaluing its stable cash flows and revenue base.
- Defensive Beta and Dividend Yield: With a beta of 0.646, the stock is historically 35% less volatile than the market, offering defensive characteristics. This is complemented by a dividend yield of approximately 7.03%, providing a tangible income stream for investors during periods of market uncertainty.
Bearish
- Severe and Persistent Underperformance: The stock has dramatically underperformed the S&P 500, lagging by 24.71% over the past six months and 20.09% year-to-date. This persistent downtrend, with the price near $38.69 versus a 52-week high of $46.76, reflects a complete lack of positive catalysts and significant selling pressure.
- Extremely Limited Analyst Coverage: With only one analyst providing estimates, ORI suffers from a severe lack of institutional research interest and inefficient price discovery. The absence of consensus price targets or ratings leaves investors with little external validation for the investment thesis and increases stock-specific volatility.
- Weak Recent Momentum and Technicals: Despite a low beta, the stock fell 2.25% over the past month while the market rose 0.74%, failing its defensive role. It is trading dangerously close to its 52-week low of $35.60, and a breakdown below this level would signal a new leg down in the established downtrend.
- Mature Business with Questionable Growth: The company operates in mature, niche insurance lines, and the provided data lacks clear revenue growth trajectory metrics. The investor narrative focuses on defensive characteristics and dividends, not growth, which may limit multiple expansion and appeal in a growth-oriented market.
ORI Technical Analysis
The stock is in a pronounced downtrend, having declined 14.99% over the past six months and 10.58% year-to-date, significantly underperforming the S&P 500 by 24.71% and 20.09% over those respective periods. With a current price near $38.69, it is trading at approximately 83% of its 52-week high of $46.76, indicating it is much closer to its 52-week low of $35.60, which suggests a potential value opportunity but also reflects persistent selling pressure and a lack of positive catalysts. Recent momentum shows a modest 2.06% gain over three months, which conflicts with the sharp 1-year decline of 4.57%, signaling a potential stabilization or failed recovery attempt; however, the stock has resumed its decline, falling 2.25% over the past month while the market rose 0.74%. The key technical levels are clear, with strong resistance at the 52-week high of $46.76 and critical support at the 52-week low of $35.60; a breakdown below $35.60 would signal a new leg down, while a sustained move above the recent recovery highs near $43 would be needed to suggest a trend reversal. With a beta of 0.646, the stock is approximately 35% less volatile than the market, which historically provided defensive characteristics but has recently failed to protect capital during the broader market advance.
Beta
0.65
0.65x market volatility
Max Drawdown
-21.4%
Largest decline past year
52-Week Range
$36-$47
Price range past year
Annual Return
+4.6%
Cumulative gain past year
| Period | ORI Return | S&P 500 |
|---|---|---|
| 1m | -2.2% | +0.1% |
| 3m | +2.1% | +13.9% |
| 6m | -15.0% | +8.5% |
| 1y | +4.6% | +25.6% |
| ytd | -10.6% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ORI Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate data are not available in the provided dataset; however, analyst estimates for the coming year project revenue of approximately $10.59 billion, providing a forward-looking benchmark for the company's scale. The company is profitable, with a trailing net margin of 10.30% and an operating margin of 13.02%, though the gross margin of 50.35% indicates a significant portion of revenue is consumed by claims and underwriting expenses, which is typical for the insurance industry. Profitability metrics are solid, with a Return on Equity (ROE) of 15.83% and a Return on Assets (ROA) of 2.95%, suggesting efficient use of shareholder capital and assets, though the low single-digit EPS of $0.08 points to potential period-specific headwinds or accounting charges. The balance sheet appears healthy with a conservative debt-to-equity ratio of 0.27, indicating minimal financial leverage, and a strong current ratio of 3.40, which signals ample liquidity to meet short-term obligations; the Price-to-Cash-Flow ratio of 9.56 suggests the market is valuing the company's operating cash flow at a reasonable multiple.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ORI Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 11.89x, while the forward PE is slightly lower at 11.61x, indicating the market expects modest earnings growth, which aligns with the single analyst's estimated EPS of $3.35 for the coming year. Compared to typical industry averages for diversified insurers, a trailing PE near 12x is generally in line or at a slight discount, suggesting the market is not assigning a premium for growth, likely due to the company's mature business model and recent stock price weakness. Historical context for the stock's own valuation multiples is not available in the provided data, but the current Price-to-Sales ratio of 1.22x and Price-to-Book ratio of 1.88x appear reasonable for a stable, dividend-paying insurer, implying the stock is not egregiously overvalued relative to its fundamentals.
PE
11.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not leverage but earnings volatility and capital allocation. The trailing EPS of $0.08, though likely anomalous, highlights susceptibility to period-specific claims or charges. A high dividend payout ratio of 83.6% constrains financial flexibility, limiting the company's ability to retain earnings for growth or to cushion against a severe underwriting cycle downturn. Revenue concentration in commercial specialty insurance, while not quantified, creates sensitivity to economic cycles in specific sectors like aviation and commercial auto.
Market & Competitive Risks: The key market risk is permanent valuation compression. The stock trades at a discount, but continued underperformance and neglect could see its multiples contract further relative to the sector. Its low beta of 0.646 failed as a defensive attribute recently, as the stock fell while the market rose, questioning its reliability. Competitive risks stem from larger, more diversified insurers with greater scale and technology investments, potentially pressuring ORI's niche positions over time. The extreme lack of analyst coverage (only one) is itself a market risk, leading to poor liquidity and exaggerated price moves on minimal news.
Worst-Case Scenario: The worst-case scenario involves a combination of a hard economic landing increasing claims in its commercial lines, a dividend cut if earnings falter (eroding its core income appeal), and a final breakdown of technical support. This could trigger a wave of selling from income-focused investors. The realistic downside is to re-test and break below the 52-week low of $35.60. From the current price near $38.69, this implies a potential loss of approximately -8%. A more severe bear case, factoring in the stock's 52-week high-to-low range, could see a drawdown towards the -21.36% max drawdown level, implying a price near $30.40, or a -21% loss from current levels.